The discovery of sulfonamide endothelin antagonists and the development of the orally active ETA antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulf onamide

  • J Med Chem. 1994 Feb 4;37(3):329-31. doi: 10.1021/jm00029a001.
P D Stein  1 ,  J T Hunt ,  D M Floyd ,  S Moreland ,  K E Dickinson ,  C Mitchell ,  E C Liu ,  M L Webb ,  N Murugesan ,  J Dickey
Affiliations
  • 1. Department of Chemistry, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000.
PMID: 8308857 DOI: 10.1021/jm00029a001